New models for the development of and access to CAR T-cell therapies for children and adolescents with cancer: an ACCELERATE multistakeholder analysis.

Pearson ADJ, Rossig C, Mackall CL, Shah NN, Baruchel A, Daems S, Anderson J, Biondi A, Bird N, Bodmer N, Brivio E, Buechner J, Calkoen FG, Cooper T, de Rojas T, Fox E, Gardner R, Ghorashian S, Heenen D, Ifversen M, Jacoby E, Juan M, Knox L, Komanduri K, Larghero J, Locatelli F, Ludwinski D, Majzner RG, McDonough J, Minard-Colin V, Nysom K, Pappo A, Park JR, Qasim W, Quintarelli C, Rives S, Rouce RH, Scobie N, Seitz C, Tasian SK, Weigel B, Weiner S, Zwaan CM, Vassal G

Open source

DOI
10.1016/s1470-2045(24)00736-8
Published
2025 Apr
Container
The Lancet. Oncology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/s1470-2045-24-00736-8,
  title = {New models for the development of and access to CAR T-cell therapies for children and adolescents with cancer: an ACCELERATE multistakeholder analysis.},
  author = {Pearson ADJ and Rossig C and Mackall CL and Shah NN and Baruchel A and Daems S and Anderson J and Biondi A and Bird N and Bodmer N and Brivio E and Buechner J and Calkoen FG and Cooper T and de Rojas T and Fox E and Gardner R and Ghorashian S and Heenen D and Ifversen M and Jacoby E and Juan M and Knox L and Komanduri K and Larghero J and Locatelli F and Ludwinski D and Majzner RG and McDonough J and Minard-Colin V and Nysom K and Pappo A and Park JR and Qasim W and Quintarelli C and Rives S and Rouce RH and Scobie N and Seitz C and Tasian SK and Weigel B and Weiner S and Zwaan CM and Vassal G},
  year = {2025},
  journal = {The Lancet. Oncology},
  doi = {10.1016/s1470-2045(24)00736-8},
  url = {https://doi.org/10.1016/s1470-2045(24)00736-8}
}

RIS

TY  - JOUR
TI  - New models for the development of and access to CAR T-cell therapies for children and adolescents with cancer: an ACCELERATE multistakeholder analysis.
AU  - Pearson ADJ
AU  - Rossig C
AU  - Mackall CL
AU  - Shah NN
AU  - Baruchel A
AU  - Daems S
AU  - Anderson J
AU  - Biondi A
AU  - Bird N
AU  - Bodmer N
AU  - Brivio E
AU  - Buechner J
AU  - Calkoen FG
AU  - Cooper T
AU  - de Rojas T
AU  - Fox E
AU  - Gardner R
AU  - Ghorashian S
AU  - Heenen D
AU  - Ifversen M
AU  - Jacoby E
AU  - Juan M
AU  - Knox L
AU  - Komanduri K
AU  - Larghero J
AU  - Locatelli F
AU  - Ludwinski D
AU  - Majzner RG
AU  - McDonough J
AU  - Minard-Colin V
AU  - Nysom K
AU  - Pappo A
AU  - Park JR
AU  - Qasim W
AU  - Quintarelli C
AU  - Rives S
AU  - Rouce RH
AU  - Scobie N
AU  - Seitz C
AU  - Tasian SK
AU  - Weigel B
AU  - Weiner S
AU  - Zwaan CM
AU  - Vassal G
PY  - 2025
JO  - The Lancet. Oncology
DO  - 10.1016/s1470-2045(24)00736-8
UR  - https://doi.org/10.1016/s1470-2045(24)00736-8
ER  - 

APA

ADJ, P., C, R., CL, M., NN, S., A, B., S, D., J, A., A, B., N, B., N, B., E, B., J, B., FG, C., T, C., T, D. R., E, F., R, G., S, G., D, H., M, I., E, J., M, J., L, K., K, K., J, L., F, L., D, L., RG, M., J, M., V, M., K, N., A, P., JR, P., W, Q., C, Q., S, R., RH, R., N, S., C, S., SK, T., B, W., S, W., CM, Z., & G, V. (2025). New models for the development of and access to CAR T-cell therapies for children and adolescents with cancer: an ACCELERATE multistakeholder analysis.. The Lancet. Oncology. https://doi.org/10.1016/s1470-2045(24)00736-8

Source records